Dr. Lal Path Labs Ltd. has consolidated the business operations of its wholly-owned subsidiary, Suburban Diagnostics (India) Private Limited, effective 18 Mar 25. This move is part of the ongoing voluntary liquidation process of Suburban, which was approved on 6 Feb 25.
Key details:
- Effective 18 Mar 25, Suburban Diagnostics' entire business undertaking has been distributed to Dr. Lal Path Labs on a going concern basis.
- In fiscal year 2024 (ending 31 Mar 24), Suburban Diagnostics contributed:
- Turnover: ₹164.03 crores (7.37% of consolidated turnover).
- Net worth: ₹126.62 crores (7.05% of consolidated net worth).
- The dissolution process of Suburban Diagnostics will be undertaken separately.